Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future …

PY Wen, M Weller, EQ Lee, BM Alexander… - Neuro …, 2020 - academic.oup.com
Glioblastomas are the most common form of malignant primary brain tumor and an important
cause of morbidity and mortality. In recent years there have been important advances in …

Hexokinase 2 in cancer: a prima donna playing multiple characters

F Ciscato, L Ferrone, I Masgras, C Laquatra… - International journal of …, 2021 - mdpi.com
Hexokinases are a family of ubiquitous exose-phosphorylating enzymes that prime glucose
for intracellular utilization. Hexokinase 2 (HK2) is the most active isozyme of the family …

Glioblastoma: current status, emerging targets, and recent advances

A Thakur, C Faujdar, R Sharma, S Sharma… - Journal of Medicinal …, 2022 - ACS Publications
Glioblastoma (GBM) is a highly malignant brain tumor characterized by a heterogeneous
population of genetically unstable and highly infiltrative cells that are resistant to …

[HTML][HTML] Integrated metabolic and epigenomic reprograming by H3K27M mutations in diffuse intrinsic pontine gliomas

C Chung, SR Sweha, D Pratt, B Tamrazi, P Panwalkar… - Cancer cell, 2020 - cell.com
Summary H3K27M diffuse intrinsic pontine gliomas (DIPGs) are fatal and lack treatments.
They mainly harbor H3. 3K27M mutations resulting in H3K27me3 reduction. Integrated …

Targeting glucose metabolism enzymes in cancer treatment: current and emerging strategies

Y Zhang, Q Li, Z Huang, B Li, EC Nice, C Huang, L Wei… - Cancers, 2022 - mdpi.com
Simple Summary Reprogramming of glucose metabolism is a hallmark of cancer and can be
targeted by therapeutic agents. Some metabolism regulators, such as ivosidenib and …

The hallmarks of glioblastoma: Heterogeneity, intercellular crosstalk and molecular signature of invasiveness and progression

F Torrisi, C Alberghina, S D'Aprile, AM Pavone… - Biomedicines, 2022 - mdpi.com
In 2021 the World Health Organization published the fifth and latest version of the Central
Nervous System tumors classification, which incorporates and summarizes a long list of …

[HTML][HTML] Repurposing non-oncology small-molecule drugs to improve cancer therapy: Current situation and future directions

L Fu, W Jin, J Zhang, L Zhu, J Lu, Y Zhen… - … Pharmaceutica Sinica B, 2022 - Elsevier
Drug repurposing or repositioning has been well-known to refer to the therapeutic
applications of a drug for another indication other than it was originally approved for …

Hexokinase 2 confers radio-resistance in hepatocellular carcinoma by promoting autophagy-dependent degradation of AIMP2

Y Zheng, Y Zhan, Y Zhang, Y Zhang, Y Liu, Y Xie… - Cell Death & …, 2023 - nature.com
With technological advancements, radiotherapy (RT) has become an effective non-surgical
treatment for hepatocellular carcinoma (HCC), comprehensively improving the local control …

[HTML][HTML] Repurposing antifungal drugs for cancer therapy

N Weng, Z Zhang, Y Tan, X Zhang, X Wei… - Journal of Advanced …, 2023 - Elsevier
Background Repurposing antifungal drugs in cancer therapy has attracted unprecedented
attention in both preclinical and clinical research due to specific advantages, such as safety …

[PDF][PDF] Integration of glucose and cardiolipin anabolism confers radiation resistance of HCC

Y Fang, Y Zhan, Y Xie, S Du, Y Chen, Z Zeng… - …, 2022 - Wiley Online Library
Abstract Background and Aims Poor response to ionizing radiation (IR) due to resistance
remains a clinical challenge. Altered metabolism represents a defining characteristic of …